Učitavanje...
Evolving Role for Pharmacotherapy in NAFLD/NASH
Nonalcoholic fatty liver disease (NAFLD) is a highly prevalent, dynamic disease that occurs across the age spectrum and can lead to cirrhosis and hepatocellular carcinoma. There are currently no US Food and Drug Administration (FDA) approved treatments for NAFLD; however, this is a field of active r...
Spremljeno u:
| Izdano u: | Clin Transl Sci |
|---|---|
| Glavni autori: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
John Wiley and Sons Inc.
2020
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7877845/ https://ncbi.nlm.nih.gov/pubmed/32583961 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cts.12839 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|